Effects of a water-soluble extract of rosemary and its purified component rosmarinic acid on xenobiotic-metabolizing enzymes in rat liver

被引:56
作者
Debersac, P
Vernevaut, MF
Amiot, MJ
Suschetet, M
Siess, MH
机构
[1] Ecole Natl Super Biol Appl Nutr & Alimentat, Inst Natl Rech Agron, Unite Mixte Rech Toxicol Alimentaire, F-21065 Dijon, France
[2] INRA, Lab Technol Prod Vegetaux, F-84914 Avignon 9, France
关键词
rosemary; cytochrome P450; glutathione S-transferase; quinone reductase; UDP-glucuronosyltransferase; rat; liver;
D O I
10.1016/S0278-6915(00)00117-4
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
The effects of a water-soluble extract (WSE) of rosemary and its purified antioxidant rosmarinic acid (RA) on xenobiotic metabolizing enzymes (XME) were studied in rat liver after dietary administration. The modulation of phase I enzymes such as cytochrome P450 (CYP) 1A, 2B, 2E1, 3A, and phase II enzymes such as glutathione S-transferase (GST), quinone reductase (QR) and UDP-glucuronosyltransferase (UGT) was evaluated by measuring enzyme activities with specific substrates. Protein levels of CYPs and rGST A1/A2, A3/A5, M1, M2 and P1 were measured using antibodies in Western blots. Caffeic acid was also studied because it results from RA biotransformation in rat after oral administration. Male SPF Wistar rats received the different compounds at 0.5% (w/w) incorporated into their diet for 2 weeks. WSE, containing RA, flavones and monoterpenes enhanced CYP 1A1, 2B1/2, 2E1 and GST (especially rGST A3/A5, M1 and M2), QR and UGT. On the contrary, no modification of XME was observed in response to RA or CA (except for a slight increase of UGT activity after CA treatment). The induction of XME by WSE could be attributed to flavones, monoterpenes or an additive effect of all components. (C) 2001 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:109 / 117
页数:9
相关论文
共 40 条
[1]   Dietary rosemary suppresses 7,12-dimethylbenz(a)anthracene binding to rat mammary cell DNA [J].
Amagase, H ;
Sakamoto, K ;
Segal, ER ;
Milner, JA .
JOURNAL OF NUTRITION, 1996, 126 (05) :1475-1480
[2]   ANTIOXIDANT AND PROOXIDANT PROPERTIES OF ACTIVE ROSEMARY CONSTITUENTS - CARNOSOL AND CARNOSIC ACID [J].
ARUOMA, OI ;
HALLIWELL, B ;
AESCHBACH, R ;
LOLIGERS, J .
XENOBIOTICA, 1992, 22 (02) :257-268
[3]   THE EFFECT OF TERPENOID COMPOUNDS ON CYTOCHROME-P-450 LEVELS IN RAT-LIVER [J].
AUSTIN, CA ;
SHEPHARD, EA ;
PIKE, SF ;
RABIN, BR ;
PHILLIPS, IR .
BIOCHEMICAL PHARMACOLOGY, 1988, 37 (11) :2223-2229
[4]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[5]   INDUCTION OF PHASE-I AND PHASE-II DRUG-METABOLIZING ENZYME MESSENGER-RNA, PROTEIN, AND ACTIVITY BY BHA, ETHOXYQUIN, AND OLTIPRAZ [J].
BUETLER, TM ;
GALLAGHER, EP ;
WANG, CH ;
STAHL, DL ;
HAYES, JD ;
EATON, DL .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1995, 135 (01) :45-57
[6]   CYTOCHROME-P450 SPECIFICITIES OF ALKOXYRESORUFIN O-DEALKYLATION IN HUMAN AND RAT-LIVER [J].
BURKE, MD ;
THOMPSON, S ;
WEAVER, RJ ;
WOLF, CR ;
MAYER, RT .
BIOCHEMICAL PHARMACOLOGY, 1994, 48 (05) :923-936
[7]   ETHOXYPHENOXAZONES, PENTOXYPHENOXAZONES, AND BENZYLOXYPHENOXAZONES AND HOMOLOGS - A SERIES OF SUBSTRATES TO DISTINGUISH BETWEEN DIFFERENT INDUCED CYTOCHROMES-P-450 [J].
BURKE, MD ;
THOMPSON, S ;
ELCOMBE, CR ;
HALPERT, J ;
HAAPARANTA, T ;
MAYER, RT .
BIOCHEMICAL PHARMACOLOGY, 1985, 34 (18) :3337-3345
[8]   Antioxidative activity and phenolic composition of pilot-plant and commercial extracts of sage and rosemary [J].
Cuvelier, ME ;
Richard, H ;
Berset, C .
JOURNAL OF THE AMERICAN OIL CHEMISTS SOCIETY, 1996, 73 (05) :645-652
[9]   EFFECTS OF ANTICARCINOGENIC MONOTERPENES ON PHASE-II HEPATIC METABOLIZING ENZYMES [J].
ELEGBEDE, JA ;
MALTZMAN, TH ;
ELSON, CE ;
GOULD, MN .
CARCINOGENESIS, 1993, 14 (06) :1221-1223
[10]  
GUENGERICH FP, 1986, J BIOL CHEM, V261, P5051